Atlas Trials

NCI COVID-19 in Cancer Patients, NCCAPS Study

Clinical trial NCT04387656 · ACTIVE_NOT_RECRUITING

Trial details

NCT number
NCT04387656
Sponsor
National Cancer Institute (NCI)
Status
ACTIVE_NOT_RECRUITING
Study type
OBSERVATIONAL
COVID-19 InfectionHematopoietic and Lymphatic System NeoplasmMalignant Solid NeoplasmMetastatic Malignant Solid Neoplasm
Start date
2020-06-05
Primary completion
2024-03-20
Enrollment
1877

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.